Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

FDA grants expedited development status to Cordox as it begins phase III trials

Dec. 16, 1998

New prostanoid compound from Ono is a useful tool for studying cardiovascular system

Dec. 15, 1998

P&G submits NDA for antiarrhythmic drug azimilide

Dec. 14, 1998

Adenosine absorption inhibitors from Kyowa Hakko useful as antiinflammatories, cardioprotectants

Dec. 11, 1998

Carbostyril compounds useful for arteriosclerosis and thrombosis

Dec. 10, 1998

Competitive LPS antagonist E-5531 suppresses LPS-mediated effects in vitro and in vivo

Dec. 9, 1998

Pharmacyclics' photoangioplasty a hot topic at RSNA

Dec. 9, 1998

Electroporation catheter safely and effectively delivers heparin to arterial wall

Dec. 8, 1998

FDA approves Verelan PM; launch scheduled for early 1999

Dec. 4, 1998

LXR initiates preclinical development of second-generation analogue of Elirex

Dec. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.